首页> 外文OA文献 >Interaction between the Cdk2/Cyclin A complex and a small molecule derived from the pRb2/p130 spacer domain: a theoretical model
【2h】

Interaction between the Cdk2/Cyclin A complex and a small molecule derived from the pRb2/p130 spacer domain: a theoretical model

机译:Cdk2 /细胞周期蛋白a复合物与源自pRb2 / p130间隔区的小分子之间的相互作用:理论模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Retinoblastoma (RB) family proteins pRb, p107 and pRb2/p130 are important cellular factors which play a well-recognized role as tumor and growth suppressors. These proteins are actively involved in the negative control of the cell cycle and their function is modulated via complex homeostatic processes, most of them involving post-translational regulation of their phosphorylation status. Interestingly, the family members p107 and pRb2/p130 share the ability to physically interact and inhibit the kinase activity of the Cdk2/Cyclin A and Cdk2/Cyclin E complexes. Regarding pRb2/p130, its inhibitory effect on Cdk2/Cyclin A activity has been attributed to the "spacer" region. Recently, a 39 aa-long pRb2/p130 spacer-derived peptide (Spa310, aa 641-679) was selected as the sequence responsible for Cdk2/Cyclin A inhibition. Following the identification of this active sequence, here we propose a computer-generated three-dimensional model of the interaction between the Cdk2/Cyclin A complex and the N-terminal nine-amino acid sequence of the Spa310 peptide. We believe this model to be useful for the rational development of peptide or peptidomimetic kinase inhibitors for negative cell cycle modulation in cancer cells.
机译:视网膜母细胞瘤(RB)家族蛋白pRb,p107和pRb2 / p130是重要的细胞因子,它们作为肿瘤和生长抑制因子发挥着公认的作用。这些蛋白质积极参与细胞周期的负调控,其功能通过复杂的体内平衡过程进行调节,其中大多数涉及其磷酸化状态的翻译后调控。有趣的是,家族成员p107和pRb2 / p130具有物理相互作用并抑制Cdk2 / Cyclin A和Cdk2 / Cyclin E复合物激酶活性的能力。关于pRb2 / p130,其对Cdk2 / Cyclin A活性的抑制作用归因于“间隔”区。最近,选择了一个39个氨基酸长的pRb2 / p130间隔子衍生肽(Spa310,氨基酸641-679)作为负责Cdk2 / Cyclin A抑制的序列。鉴定出该活性序列之后,在这里我们提出了计算机生成的三维模型,该模型涉及Cdk2 / Cyclin A复合物与Spa310肽的N端九氨基酸序列之间的相互作用。我们相信该模型对于合理开发用于癌细胞中负细胞周期调节的肽或拟肽激酶抑制剂是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号